Guangzhou Wondfo Biotech Co.,Ltd reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported sales was CNY 581.74 million compared to CNY 800.28 million a year ago. Net income was CNY 84.4 million compared to CNY 189.14 million a year ago.
Basic earnings per share from continuing operations was CNY 0.18 compared to CNY 0.39 a year ago. Diluted earnings per share from continuing operations was CNY 0.18 compared to CNY 0.39 a year ago.